Avalo Therapeutics Inc (AVTX) — Cash Flow Quality Index
Avalo Therapeutics Inc (AVTX) has a Cash Flow Quality Index of -0.50x as of September 2024. Operating cash flow of $-11.53 Million is below net income of $23.04 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore AVTX asset base for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Avalo Therapeutics Inc Cash Flow Quality Index (2017–2017)
Historical Cash Flow Quality Index for Avalo Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check AVTX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Avalo Therapeutics Inc (2017–2017)
Year-by-year earnings quality comparison for Avalo Therapeutics Inc. For live market cap and the full company financial profile, see AVTX stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2017 | 1.05x | $12.52 Million | $11.87 Million | — |